Literature DB >> 6607624

An imaging approach to persistent neonatal jaundice.

D R Kirks, R E Coleman, H C Filston, E R Rosenberg, D F Merten.   

Abstract

Fifteen patients with persistent neonatal jaundice were evaluated by sonography and radionuclide scintigraphy. The sonographic features of both neonatal hepatitis and biliary atresia are nonspecific. Hepatobiliary scintigraphy after phenobarbital pretreatment in patients with neonatal hepatitis demonstrates normal hepatic extraction and delayed tracer excretion into the gastrointestinal tract. If there is neonatal hepatitis with severe hepatocellular damage, the hepatic extraction of tracer activity is decreased and excretion may be delayed or absent. Patients under 3 months of age with biliary atresia have normal hepatic extraction of tracer with no excretion into the gastrointestinal tract. Sonography in patients with a choledochal cyst shows a cystic mass in the porta hepatis with associated bile-duct dilatation. Hepatobiliary scintigraphy confirms that the choledochal cyst communicates with the biliary system. Initial sonography demonstrates hepatobiliary anatomy; subsequent phenobarbital-enhanced radionuclide scintigraphy determines hepatobiliary function. An expedient diagnostic approach is recommended for the evaluation of persistent neonatal jaundice.

Entities:  

Mesh:

Year:  1984        PMID: 6607624     DOI: 10.2214/ajr.142.3.461

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Diagnostic laparoscopy-assisted cholangiography in infants with prolonged jaundice.

Authors:  Tadaharu Okazaki; Go Miyano; Atsuyuki Yamataka; Hiroyuki Kobayashi; Hiroyuki Koga; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-12-08       Impact factor: 1.827

Review 2.  Imaging of biliary disorders in children.

Authors:  Céline Rozel; Laurent Garel; Françoise Rypens; Loïc Viremouneix; Chantale Lapierre; Jean Claude Décarie; Josée Dubois
Journal:  Pediatr Radiol       Date:  2010-09-24

Review 3.  Ultrasound findings in paediatric cholestasis: how to image the patient and what to look for.

Authors:  Marco Di Serafino; Matilde Gioioso; Rosa Severino; Francesco Esposito; Norberto Vezzali; Federica Ferro; Piernicola Pelliccia; Maria Grazia Caprio; Raffaele Iorio; Gianfranco Vallone
Journal:  J Ultrasound       Date:  2019-02-12

4.  Betamethasone in plus phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy in infants with jaundice.

Authors:  D K Gupta; A R Charles; M Srinivas; S Dave; C S Bal
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

Review 5.  Fibropolycystic liver disease in children.

Authors:  Myka Call Veigel; Julia Prescott-Focht; Michael G Rodriguez; Reza Zinati; Lei Shao; Charlotte A W Moore; Lisa H Lowe
Journal:  Pediatr Radiol       Date:  2008-12-16

6.  Pre-operative ultrasonographic diagnosis of biliary atresia--with reference to the presence or absence of the extrahepatic bile duct.

Authors:  Takashi Azuma; Tetsuro Nakamura; Masashi Nakahira; Ken Harumoto; Tatsuo Nakaoka; Takayoshi Moriuchi
Journal:  Pediatr Surg Int       Date:  2003-05-15       Impact factor: 1.827

7.  Ten minute radiopharmaceutical test in biliary atresia.

Authors:  M A el Tumi; M B Clarke; J J Barrett; A P Mowat
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

8.  Bile-plug syndrome.

Authors:  M A Mahr; C Hugosson; H M Nazer; S A Saad; M A Ali
Journal:  Pediatr Radiol       Date:  1988

9.  Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center.

Authors:  Neha Kwatra; Eglal Shalaby-Rana; Srikala Narayanan; Parvathi Mohan; Sunil Ghelani; Massoud Majd
Journal:  Pediatr Radiol       Date:  2013-05-11

10.  Serial ultrasonic examination to differentiate biliary atresia from neonatal hepatitis--special reference to changes in size of the gallbladder.

Authors:  S Ikeda; Y Sera; M Akagi
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.